Relapsing MRI-negative myelitis associated with myelin-oligodendrocyte glycoprotein autoantibodies: a case report
Abstract Background Serum antibodies to myelin-oligodendrocyte glycoprotein (MOG) are biomarkers of MOG-IgG-associated disorder (MOGAD), a demyelinating disease distinct from both multiple sclerosis and aquaporin-4-IgG neuromyelitis optica spectrum disorder. The phenotype of MOGAD is broad and inclu...
Main Authors: | Jan Kolcava, Aneta Rajdova, Eva Vlckova, Pavel Stourac, Josef Bednarik |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2022-08-01
|
Series: | BMC Neurology |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12883-022-02837-5 |
Similar Items
-
Complement-dependent cytotoxicity of human autoantibodies against myelin oligodendrocyte glycoprotein
by: Kuniko Kohyama, et al.
Published: (2023-02-01) -
Case report: A patient with meningoencephalitis followed by asymptomatic anti-myelin oligodendrocyte glycoprotein antibody-related disorder
by: Yunjie Li, et al.
Published: (2022-09-01) -
Patient Pathway to Diagnosis of Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disease (MOGAD): Findings from a Multinational Survey of 204 Patients
by: Jonathan D. Santoro, et al.
Published: (2023-04-01) -
Sentinel seizure heralding Myelin oligodendrocyte glycoprotein (MOG) antibody-associated disease
by: Shambaditya Das, et al.
Published: (2023-03-01) -
Clinical characteristics of myelin oligodendrocyte glycoprotein antibody-associated disease according to their epitopes
by: Jin Myoung Seok, et al.
Published: (2023-06-01)